The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N011396 / 01 from 09.12.2009 issued by GlaxoSmithKline Consumer Helsker, United Kingdom, registration certificate P N015458 / 02 dated 09.12.2009 issued by GlaxoSmithKline Consumer Helsker, United Kingdom, registration certificate P N015458 / 01 dated January 27, 2009 issued by GlaxoSmithKline Consumer Helsker, United Kingdom ):
Solpadein (trade name of the medicinal product)
Codeine + Caffeine + Paracetamol (international non-proprietary or grouping or chemical name)
Capsules, tablets, soluble, tablets (dosage form, dosage)
SmithKlein Beecham SA, Spain AVDA de Ajalvir, KM 2500 - 28806, Alcala de Henares, Madrid, Spain (name and address of the location of the manufacturer of the medicinal product)
JSC "GlaxoSmithKline Helsker", by an authorized legal entity, annul the state registration of the medicinal product.